What Does the FDA Restriction on Alzheimer’s Drug Mean for Patients?

Published on July 9, 2021

The Food and Drug Administration changed its recommendations for the newly approved Alzheimer’s drug Aduhelm after an intense public backlash. The agency modified the prescribing instructions for the drug to limit its use and efficacy only to patients with mild to moderate…

Read Full Article (External Site)